Global Blood Collection Robots Market Growth 2026-2032
The global Blood Collection Robots market size is predicted to grow from US$ 3.06 million in 2025 to US$ 50.58 million in 2032; it is expected to grow at a CAGR of 39.4% from 2026 to 2032.
Blood collection robots are medical robot systems designed for hospital blood collection windows, physical examination centers, and medical laboratory pre-processing scenarios. Their core capabilities include using near-infrared and ultrasound technology to detect veins, reconstructing vein images using 3D technology, and then using AI algorithms to intelligently analyze the images, selecting the most appropriate location and method for needle insertion to achieve automated intravenous puncture blood testing. The system typically integrates identity verification, medical order matching, catheter and needle supply, disinfection, pulse pressure, quantitative blood collection, catheter replacement, mixing, hemostasis, and traceability recording, forming an auditable closed-loop blood collection workflow. This aims to improve the success rate of first-time punctures, reduce pre-test errors, and alleviate the shortage of blood collection personnel. In 2025, the global production of blood collection robots was approximately 32 units, with a unit price of approximately US$97,800 and a gross profit margin of approximately 45%?65%.
Currently, blood collection still faces many challenges, with poor visibility and inaccurate punctures being the main issues. Infants' blood vessels are very thin, and those with thicker fat layers or darker skin tones often have blood vessels that are difficult to visually assess. The failure rate for first-time intravenous punctures in children is around 44%, and repeated punctures increase the psychological stress on nurses. Due to various factors, the efficiency of blood collection and testing in many hospitals is not high. During peak blood collection periods, the average waiting time for patients is 24 minutes, with over 64.5% of patients waiting more than 15 minutes. Even in commercial medical examination institutions, the average time for a ?trial? blood collection exceeds 10 minutes. From a clinical perspective, many hospitals face the pain point of high blood collection pressure, creating a significant demand for blood collection robots. Furthermore, the long-term shortage of nursing staff has spurred the need for ?substitute labor.? Currently, automation solutions exist for queuing, blood collection tube sorting, blood diagnosis, and report output; only the blood collection process still relies on manual labor. Future machine replacement will complete the automated closed loop of blood diagnosis. From the perspective of practical applications in the medical field, blood collection robots are still in their early stages of development. Due to factors such as cost and hospital procurement processes, currently, most hospitals that can implement them are large tertiary hospitals. Companies in this sector are primarily focused on research and development; future commercialization may require more external CSOs (Contract Sales Organizations) to gradually penetrate hospitals. Globally, the European and American markets have significant potential, as nurses in these countries have lower success rates for manual intravenous punctures, making machine replacement a priority. However, cost reduction is a key factor for commercialization. Currently, blood collection robots entering the market are expensive. Significant commercial and social value will only be realized after technological iterations and their integration into primary healthcare systems.
LP Information, Inc. (LPI) ' newest research report, the ?Blood Collection Robots Industry Forecast? looks at past sales and reviews total world Blood Collection Robots sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Collection Robots sales for 2026 through 2032. With Blood Collection Robots sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Collection Robots industry.
This Insight Report provides a comprehensive analysis of the global Blood Collection Robots landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Collection Robots portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Blood Collection Robots market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Collection Robots and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Collection Robots.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Collection Robots market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Blood collection robots are medical robot systems designed for hospital blood collection windows, physical examination centers, and medical laboratory pre-processing scenarios. Their core capabilities include using near-infrared and ultrasound technology to detect veins, reconstructing vein images using 3D technology, and then using AI algorithms to intelligently analyze the images, selecting the most appropriate location and method for needle insertion to achieve automated intravenous puncture blood testing. The system typically integrates identity verification, medical order matching, catheter and needle supply, disinfection, pulse pressure, quantitative blood collection, catheter replacement, mixing, hemostasis, and traceability recording, forming an auditable closed-loop blood collection workflow. This aims to improve the success rate of first-time punctures, reduce pre-test errors, and alleviate the shortage of blood collection personnel. In 2025, the global production of blood collection robots was approximately 32 units, with a unit price of approximately US$97,800 and a gross profit margin of approximately 45%?65%.
Currently, blood collection still faces many challenges, with poor visibility and inaccurate punctures being the main issues. Infants' blood vessels are very thin, and those with thicker fat layers or darker skin tones often have blood vessels that are difficult to visually assess. The failure rate for first-time intravenous punctures in children is around 44%, and repeated punctures increase the psychological stress on nurses. Due to various factors, the efficiency of blood collection and testing in many hospitals is not high. During peak blood collection periods, the average waiting time for patients is 24 minutes, with over 64.5% of patients waiting more than 15 minutes. Even in commercial medical examination institutions, the average time for a ?trial? blood collection exceeds 10 minutes. From a clinical perspective, many hospitals face the pain point of high blood collection pressure, creating a significant demand for blood collection robots. Furthermore, the long-term shortage of nursing staff has spurred the need for ?substitute labor.? Currently, automation solutions exist for queuing, blood collection tube sorting, blood diagnosis, and report output; only the blood collection process still relies on manual labor. Future machine replacement will complete the automated closed loop of blood diagnosis. From the perspective of practical applications in the medical field, blood collection robots are still in their early stages of development. Due to factors such as cost and hospital procurement processes, currently, most hospitals that can implement them are large tertiary hospitals. Companies in this sector are primarily focused on research and development; future commercialization may require more external CSOs (Contract Sales Organizations) to gradually penetrate hospitals. Globally, the European and American markets have significant potential, as nurses in these countries have lower success rates for manual intravenous punctures, making machine replacement a priority. However, cost reduction is a key factor for commercialization. Currently, blood collection robots entering the market are expensive. Significant commercial and social value will only be realized after technological iterations and their integration into primary healthcare systems.
LP Information, Inc. (LPI) ' newest research report, the ?Blood Collection Robots Industry Forecast? looks at past sales and reviews total world Blood Collection Robots sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Collection Robots sales for 2026 through 2032. With Blood Collection Robots sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Collection Robots industry.
This Insight Report provides a comprehensive analysis of the global Blood Collection Robots landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Collection Robots portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Blood Collection Robots market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Collection Robots and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Collection Robots.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Collection Robots market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Fixed Kiosk Station
- Mobile Cart/Desktop Workstation
- Blood Collection and Puncture Module
- Multi-technology Modules
- Direct Sales
- Distributor Sales
- Hospital
- Health Checkup Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Veebot System
- BHealthCare(HEIVA)
- Vitestro
- Jiangsu Hagong Intelligent Robot Co.,Ltd.
- Beijing mainashi Surgical Robot Technology Co. Ltd.
- Chengdu Kairui Medical Technology Co., Ltd. (Aixam)
- What is the 10-year outlook for the global Blood Collection Robots market?
- What factors are driving Blood Collection Robots market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doBlood Collection Robots market opportunities vary by end market size?
- How does Blood Collection Robots break out by Type, by Application?
%%
